Invivoscribe Submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to Support Daiichi Sankyo Submissions for QuizartinibVIEW PRESS RELEASE →Invivoscribe Marketing2018-12-02T23:38:40-08:00December 2nd, 2018|Press Releases|